Company
Biontech Ag
9 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 18303642 | Compositions and Methods for Diagnosis and Treatment of Cancer | C07K, G01N | Apr 19, 2023 | |
| 18186914 | CORONAVIRUS VACCINE | C12N, A61K | Mar 19, 2023 | |
| 18085206 | MODULAR DRUG PRODUCTION SYSTEM | G16B, B01L, B01D, B01F, A61K | Dec 19, 2022 | |
| 18071499 | CORONAVIRUS VACCINE | A61K | Nov 28, 2022 | |
| 18049593 | MODIFICATION OF RNA, PRODUCING AN INCREASED TRANSCRIPT STABILITY AND TRANSLATION EFFICIENCY | C12N | Oct 24, 2022 | |
| 17931215 | METHODS AND COMPOSITIONS FOR STIMULATING IMMUNE RESPONSE | C12N, A61K | Sep 11, 2022 | |
| 17817033 | MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 | A61K, G01N, C07K | Aug 2, 2022 | |
| 17688707 | RECOMBINANT VACCINES AND USE THEREOF | A61K, C07K | Mar 6, 2022 | |
| 17669117 | SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 | C07D, A61P | Feb 9, 2022 | |
| 17590550 | SUBSTITUTED IMIDAZOQUINOLINES | C07D, A61P | Jan 31, 2022 | |
| 17576170 | INDIVIDUALIZED VACCINES FOR CANCER | C12Q, G16B, A61K | Jan 13, 2022 | |
| 17565842 | RNA constructs and uses thereof | B82Y, C12P, A61K, C12N, A61P | Dec 29, 2021 | Oct 9, 2023 |
| 17565921 | RNA constructs and uses thereof | A61P, B82Y, C12N, A61K, C12P | Dec 29, 2021 | Apr 8, 2024 |
| 18258343 | Therapeutic RNA for Treating Cancer | A61P, A61K | Dec 19, 2021 | |
| 18266135 | RNA MANUFACTURING | C12P, A61K | Dec 6, 2021 | |
| 17539157 | PREDICTING IMMUNOGENICITY OF T CELL EPITOPES | G16B, A61K, C12Q | Nov 29, 2021 | |
| 18036681 | PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME | A61K | Nov 14, 2021 | |
| 18035172 | MONOCLONAL ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 PROTEIN AND THEIR USE IN MEDICINE | C07K, G01N | Nov 10, 2021 | |
| 17495571 | METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS | A61K, G16B, C07K | Oct 5, 2021 | |
| 17494601 | RNA Replicon for Versatile and Efficient Gene Expression | C12N | Oct 4, 2021 |